HOME › DRUGS › ROSIGLITAZONE;GLIMEPIRIDE
ACTIVE SUBSTANCE / INN

ROSIGLITAZONE;GLIMEPIRIDE

Brand name(s): Avaglim
EMA LISTED
WITHDRAWN
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Rosiglitazone;Glimepiride
REGULATORS
EMA
SPONSORS / MAH
SmithKline Beecham Ltd
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AvaglimSmithKline Beecham LtdWithdrawn27/06/2006Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ROSIGLITAZONE;GLIMEPIRIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →